Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments

• 期刊名称Journal of Clinical Pharmacy and Therapeutics
• 作者Hirai, T.; Yamaga, R.; Fujita, A.; Itoh, T.
• 印刷ISSN0269-4727
• 文件大小668.90KB
• 发表时间2018-06-16
• DOI10.1111/jcpt.12720